235 related articles for article (PubMed ID: 8995604)
1. Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.
Platt EJ; Madani N; Kozak SL; Kabat D
J Virol; 1997 Feb; 71(2):883-90. PubMed ID: 8995604
[TBL] [Abstract][Full Text] [Related]
2. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
[TBL] [Abstract][Full Text] [Related]
3. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
Platt EJ; Durnin JP; Kabat D
J Virol; 2005 Apr; 79(7):4347-56. PubMed ID: 15767435
[TBL] [Abstract][Full Text] [Related]
4. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
Platt EJ; Kuhmann SE; Rose PP; Kabat D
J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
6. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
Brighty DW; Rosenberg M; Chen IS; Ivey-Hoyle M
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7802-5. PubMed ID: 1909031
[TBL] [Abstract][Full Text] [Related]
7. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
Willey RL; Theodore TS; Martin MA
J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
[TBL] [Abstract][Full Text] [Related]
8. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity.
Dirckx L; Lindemann D; Ette R; Manzoni C; Moritz D; Mous J
Virus Res; 1990 Dec; 18(1):9-20. PubMed ID: 2082620
[TBL] [Abstract][Full Text] [Related]
9. Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1.
Platt EJ; Kozak SL; Kabat D
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):871-82. PubMed ID: 10875613
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
Thali M; Furman C; Helseth E; Repke H; Sodroski J
J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
[TBL] [Abstract][Full Text] [Related]
11. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.
Devico A; Silver A; Thronton AM; Sarngadharan MG; Pal R
Virology; 1996 Apr; 218(1):258-63. PubMed ID: 8615032
[TBL] [Abstract][Full Text] [Related]
12. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.
Ivey-Hoyle M; Culp JS; Chaikin MA; Hellmig BD; Matthews TJ; Sweet RW; Rosenberg M
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):512-6. PubMed ID: 1899141
[TBL] [Abstract][Full Text] [Related]
13. Coreceptor function of mutant human CD4 molecules without affinity to gp120 of human immunodeficiency virus.
Tachibana M; Siddiqi MA; Ikegami Y; Eshima K; Shirota-Someya Y; Tahara-Hanaoka S; Koito A; Iizuka M; Shinohara N
J Biol Chem; 2000 Jul; 275(27):20288-94. PubMed ID: 10779509
[TBL] [Abstract][Full Text] [Related]
14. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP
J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
[TBL] [Abstract][Full Text] [Related]
17. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
Koito A; Harrowe G; Levy JA; Cheng-Mayer C
J Virol; 1994 Apr; 68(4):2253-9. PubMed ID: 8139010
[TBL] [Abstract][Full Text] [Related]
18. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
Willey RL; Martin MA; Peden KW
J Virol; 1994 Feb; 68(2):1029-39. PubMed ID: 7904656
[TBL] [Abstract][Full Text] [Related]
19. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.
Kabat D; Kozak SL; Wehrly K; Chesebro B
J Virol; 1994 Apr; 68(4):2570-7. PubMed ID: 8139036
[TBL] [Abstract][Full Text] [Related]
20. Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.
Leavitt M; Park EJ; Sidorov IA; Dimitrov DS; Quinnan GV
J Virol; 2003 Jan; 77(1):560-70. PubMed ID: 12477860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
